Physician profile
David E Mahon
NPI 1710983325
$721.65
in general payments reported to CMS, 2019-2025
12 companies · $65.02 in 2025
The $65.02 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $42.55 · 2021: $26.56 · 2023: $126 · 2024: $245 · 2025: $65.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $277.36 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $256.05 | 2019-2024 | Oasis, Renasys Go V2 Home, Pico |
| Olympus America INC. | $41.83 | 2019-2023 | Itind System, Soltive |
| Urgo Medical North America, LLC | $23.54 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Solventum Corporation | $22.07 | 2024 | Activ.A.C. |
| Mimedx Group, INC. | $16.83 | 2025 | |
| Conmed Corporation | $15.86 | 2024 | Airseal |
| Kci USA, INC. | $14.45 | 2020 | |
| Procept Biorobotics Corporation | $14.14 | 2021 | |
| Lemaitre Vascular, INC. | $14.04 | 2024 | Artegraft Vascular Graft |
| Osiris Therapeutics INC. | $13.06 | 2019 | |
| Abbott Laboratories | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mahon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.